Evidence map›Paper›PMID 23546880›Full record

ArticleThe Journal of biological chemistry2013

TGF-β-activated kinase 1 (Tak1) mediates agonist-induced Smad activation and linker region phosphorylation in embryonic craniofacial neural crest-derived cells.

Kenji Yumoto, Penny S Thomas, Jamie Lane, Kouichi Matsuzaki, Maiko Inagaki, Jun Ninomiya-Tsuji, Gregory J Scott, Manas K Ray, Mamoru Ishii, Robert Maxson and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. International journal of molecular sciences · 2025
    Article
  5. Article
  6. Article
  7. Functional and Genetic Analyses Unveil the Implication ofInternational journal of molecular sciences · 2024
    Article
  8. Review
  9. Review
  10. Article
  11. Emerging role of TAK1 in the regulation of skeletal muscle mass.BioEssays : news and reviews in molecular, cellular and developmental biology · 2023
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Kenji YumotoDepartment of Biologic and Materials Sciences, University of Michigan, Ann Arbor, Ann Arbor, MI 48109, USA.
Penny S Thomas
Jamie Lane
Kouichi Matsuzaki
Maiko Inagaki
Jun Ninomiya-Tsuji
Gregory J Scott
Manas K Ray
Mamoru Ishii
Robert Maxson
Yuji Mishina
Vesa Kaartinen
University of Michigan–Ann Arbor · USNorth Carolina State University · USUniversity of Southern California · USKansai Medical University · JPNational Institute of Environmental Health Sciences · USNational Institutes of Health · US

Funding

NIEHS Knock Out Mouse Core (KOMC) Annual ReportZICES102425 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI RAY, MANAS · 2010 to 2025
$20.1M
CELLULAR AND MOLECULAR BIOLOGY AT MICHIGANT32GM007315 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PUTHENVEEDU, MANOJKUMAR A · 1985 to 2021
$12.8M
THE ROLE OF TGF-BETA3 IN PALATOGENESISR01DE013085 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KAARTINEN, VESA M · 2001 to 2014
$5.4M
Molecular pathogenesis of craniosynostosis caused by enhanced BMP signalingR01DE020843 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MISHINA, YUJI · 2010 to 2019
$4.9M
Genetics Of Morphogenetic Mechanism During Mouse DevelopZ01ES071003 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI MISHINA, YUJI · 1998 to 2008
$4.3M
Activin Receptor-Like Kinase-2 in Cardiac MorphogenesisR01HL074862 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KAARTINEN, VESA M · 2004 to 2011
$2.6M
MicroCT 100S10RR026475 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KOHN, DAVID H. · 2010 to 2010
$381k
Intramural NIH HHS Z01 ES071003NCRR NIH HHS S10 RR026475NCRR NIH HHS S10RR026475-01NHLBI NIH HHS HL074862NHLBI NIH HHS R01 HL074862NIDCR NIH HHS R01 DE013085NIDCR NIH HHS R01 DE020843NIDCR NIH HHS R01DE020843NIEHS NIH HHS ES071003-11NIGMS NIH HHS T32 GM007315
6 · The paper itself

Abstract

backgroundThe role of Smad-independent TGF-β signaling in craniofacial development is poorly elucidated.

resultsIn craniofacial mesenchymal cells, Tak1 regulates both R-Smad C-terminal and linker region phosphorylation in TGF-β signaling.

conclusionTak1 plays an irreplaceable role in craniofacial ecto-mesenchyme during embryogenesis. SIGNIFICANCE: Understanding the mechanisms of TGF-β signaling contributes to knowledge of pathogenetic mechanisms underlying common craniofacial birth defects. Although the importance of TGF-β superfamily signaling in craniofacial growth and patterning is well established, the precise details of its signaling mechanisms are still poorly understood. This is in part because of the concentration of studies on the role of the Smad-dependent (so-called "canonical") signaling pathways relative to the Smad-independent ones in many biological processes. Here, we have addressed the role of TGF-β-activated kinase 1 (Tak1, Map3k7), one of the key mediators of Smad-independent (noncanonical) TGF-β superfamily signaling in craniofacial development, by deleting Tak1 specifically in the neural crest lineage. Tak1-deficient mutants display a round skull, hypoplastic maxilla and mandible, and cleft palate resulting from a failure of palatal shelves to appropriately elevate and fuse. Our studies show that in neural crest-derived craniofacial ecto-mesenchymal cells, Tak1 is not only required for TGF-β- and bone morphogenetic protein-induced p38 Mapk activation but also plays a role in agonist-induced C-terminal and linker region phosphorylation of the receptor-mediated R-Smads. Specifically, we demonstrate that the agonist-induced linker region phosphorylation of Smad2 at Thr-220, which has been shown to be critical for full transcriptional activity of Smad2, is dependent on Tak1 activity and that in palatal mesenchymal cells TGFβRI and Tak1 kinases mediate both overlapping and distinct TGF-β2-induced transcriptional responses. To summarize, our results suggest that in neural crest-derived ecto-mesenchymal cells, Tak1 provides a critical point of intersection in a complex dialogue between the canonical and noncanonical arms of TGF-β superfamily signaling required for normal craniofacial development.

Indexed as

Protein Processing, Post-TranslationalAmino Acid MotifsAnimalsCells, CulturedCleft PalateEctodermFemaleGene Expression Regulation, DevelopmentalHeadMaleMandibleMAP Kinase Kinase Kinase 7MAP Kinase Kinase KinasesMiceMice, TransgenicMitogen-Activated Protein KinasesMAP Kinase Kinase Kinase 7MAP Kinase Kinase KinasesMitogen-Activated Protein KinasesProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type ISmad ProteinsSmad Proteins, Receptor-RegulatedTGF-beta Superfamily ProteinsWnt1 ProteinWnt1 protein, mouseBone Morphogenetic Protein (BMP)Craniofacial Birth DefectsCraniofacial DevelopmentEmbryoLinker Region PhosphorylationSMAD Transcription FactorTransforming Growth Factor beta (TGFbeta)

Identifiers

PMID23546880
PMCPMC3650384
OpenAlexW2006016083

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.